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Abstract
Background: Transgenerational epigenetic inheritance has been posited as a possible contributor to the observed
heritability of metabolic syndrome (MetS). Yet the extent to which estimates of epigenetic inheritance for DNA
methylation sites are inflated by environmental and genetic covariance within families is still unclear. We applied
current methods to quantify the environmental and genetic contributors to the observed heritability and familial
correlations of four previously associated MetS methylation sites at three genes (CPT1A, SOCS3 and ABCG1) using
real data made available through the GAW20.
Results: Our findings support the role of both shared environment and genetic variation in explaining the
heritability of MetS and the four MetS cytosine-phosphate-guanine (CpG) sites, although the resulting heritability
estimates were indistinguishable from one another. Familial correlations by type of relative pair generally followed
our expectation based on relatedness, but in the case of sister and parent pairs we observed nonsignificant trends
toward greater correlation than expected, as would be consistent with the role of shared environmental factors in
the inflation of our estimated correlations.
Conclusions: Our work provides an interesting and flexible statistical framework for testing models of epigenetic
inheritance in the context of human family studies. Future work should endeavor to replicate our findings and
advance these methods to more robustly describe epigenetic inheritance patterns in human populations.
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Background
Metabolic syndrome (MetS) is a widespread problem in
the United States, with 35% of U.S. adults having MetS
in 2012 [1]. It is often defined by having at least
three of the following: increased waist circumference
(≥88 cm for women or ≥ 100 cm for men), high triglycerides
(≥150 mg/dL), low high-density lipoprotein cholesterol
(≤40 mg/dL for men, ≤50 mg/dL for women), hypertension
(> 130 mmHg systolic and/or > 85 mmHg diastolic), and el-
evated fasting blood glucose (≥100 mg/dL or previous diag-
nosis of diabetes), or reliance on medications to correct
these disturbances [2]. The MetS epidemic is on the rise in
much of the world with younger generations experiencing
earlier onset and higher lifetime disease burden [3].
Given the heritability that remains unexplained by estab-
lished genetic variants for the subcomponents of MetS,
transgenerational epigenetic inheritance has been posited
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as a possible contributor to the observed heritability [4].
Although cytosine-phosphate-guanine (CpG) methylation
may be trans-generationally inherited, it is also possible
that CpG sites are mediators of the effect of inherited
genetic variant(s) on gene expression, or are biomarkers
for the complex patterning of social or environmental
risk factors. In fact, recent work has shed light on the com-
plexity of how environmental risk factors within popula-
tions and across generations interact with both genetic
variation and transgenerational epigenetic inheritance [5].
Yet substantial ethical and methodologic challenges remain
to observationally or experimentally identifying transge-
nerational epigenetic inheritance in humans [4].
To date, CpG methylation sites at CPT1A, SOCS3, and
ABCG1 have been associated with MetS, or its subcom-
ponents (CPT1A, ABCG1) [6–12]. The extent to which
these associations are driven by environmental or genetic
mechanisms is a source of debate and is one that has
great practical implications for tailoring public health
prevention. One approach to understanding the under-
lying mechanism is the estimation of heritability or famil-
ial correlation at CpG sites, which has been done across
the methylome using twin-based studies [13], extended
family-based samples from multigenerational pedigrees
[7, 14], and in proof-of-principle studies in animal models
[4]. However, the extent to which heritability or correla-
tions estimates are inflated by environmental and genetic
covariance within families is still unclear. Thus, robust
estimates of heritability, unrelated to recapitulated envir-
onmental factors or inherited genetic variation, are needed
to inform our understanding of the role of epigenetic in-
heritance in metabolic dysfunction as well as inform the
origins of current intergenerational patterning of health
disparities.
We aimed to apply current methods (ie, variance com-
ponent models and correlations) to quantify the environ-
mental and genetic contributors to the observed similarity
within families at four specific MetS CpG sites. To do this,
we leveraged data on 1105 adults made available through
the Genetic Analysis Workshop (GAW20) to estimate the
heritability at CpG sites near 3 genes (CPT1A, SOCS3,
and ABCG1), adjusting for demographic, environmental
factors and genetic variation in a stepwise fashion using
both fixed and random effects. Then we estimated familial
correlations of methylation profiles at these CpG sites,
both with and without adjustments, and across relative
pair types.
Methods
GAW20 methylation and genotypic data
The real GAW20 methylation and genotypic data come
from 188 extended families collected from Minnesota and
Utah as part of the Genetics of Lipid Lowering Drugs and
Diet Network (GOLDN) study [14]. Our analytic sample
consisted of 1105 GOLDN participants with MetS at base-
line, as defined by the criteria described above [2], and
995 adults were typed for methylome-wide DNA methyla-
tion patterns at 485,577 CpG sites using the HM450 array
following bisulfite conversion (Illumina Inc., San Diego,
CA, USA) of DNA from sorted CD4+ lymphocytes at visit
2. We excluded 1 individual from a monozygotic pair and
1 individual with missing smoking status from the statis-
tical analyses, leading to a final sample of 1103 in the
MetS and 993 individuals and CpG site heritability/correl-
ation analyses (in 3682 and 3176 pairs, respectively, that
were between first and fifth relatives). A subset of
716 individuals also had genotyping from the Affymetrix
Genome-Wide Human Single Nucleotide Polymorphism
(SNP) Array 6.0 (Affymetrix, Inc., Santa Clara, CA, USA).
MetS methylation loci
From the literature we selected 4 CpG sites that were
previously associated with MetS (eg, CPT1A, SOCS3), or
with Type 2 diabetes, lipids, and obesity-related traits (eg
CPT1A, ABCG1) including: cg00574958 and cg17058475
near CPT1A [6, 7, 9, 11, 12]; cg18181703 in SOCS3 [10];
and cg06500161 in ABCG1 [7–9, 12].
Heritability analyses
We estimated the narrow sense heritability of MetS [2]
and 4 CpG methylation sites using variance component
models implemented in SOLAR version 6.6.2 [15]. The
CpG site residuals were scaled by 25 for stability in our
SOLAR models.
No fixed effect covariates were included in our crude
heritability models (Model 0). Further analyses accounted
for an individual’s age and sex (female, male as referent),
quadratic age effects, and their interactions with sex
(Model 1). In all subsequent models, environmental covar-
iates were added into the models in the following se-
quence: center (Minnesota, Utah as referent; Model 2a),
followed by cigarette smoking status (former, current,
never as referent; Model 2b). We then screened all these
demographic and environmental fixed effects, including
only the effects that remained suggestively significant in
the heritability models (P value < 0.1). Then using the
fixed effects identified in the reduced model above, we
added household variance components to account for sib-
lings and half-siblings within 15 years of each other, who
were the relative pair type most likely to have shared an
‘early life’ environment at some point during their child-
hood or adolescence (Model 3a). Separately we added a
variance component for parent pairs (if an individual was
in more than 1 parental pair, taking the pairing resulting
in the youngest offspring), who were the relative pair type
most likely to have shared ‘later life’ environmental expo-
sures (Model 3b). Lastly, in a fourth modeling strategy
that included the same fixed effects from the reduced
Fernández-Rhodes et al. BMC Genetics 2018, 19(Suppl 1):69 Page 8 of 140
model (Models 1 and 2), we screened at P value < 0.05
local cis-acting genetic variants at each locus. To select
these variants, we used publicly available 1000 Genomes
phase 3 CEU (Northern Europeans from Utah) reference
data to query two independent sets (pairwise linkage dis-
equilibrium r2 < 0.05, estimated in PLINK version 1.07)
[16] of genetic variants: local variants (±250 kb of the
CpG site[s]), and distant variants (250–500 kb) as done
previously [12]. This resulted in n = 8, 19, and 21 local and
n = 6, 7, and 13 distant variants screened in heritability
models for CpG sites at CPT1A, SOCS3, and ABCG1,
respectively.
Table 1 Variation in estimated additive heritability at three MetS-related CpG methylation loci adjusted (Model 0) and across
increasing adjustments for demographic and environmental factors (Models 1–2), in a reduced model of fixed effects, and after
including to this reduced model separate variance components for shared early life (Model 3a) and late life environment (Model 3b)
in 993 participants from 188 families with all covariates and methylation information at visit 2 in the GOLDN study
Modela Log Likelihood h2 (c2) SE of h2 (c2) P value of h2 (c2) Prop Var Exp by Cov
cg00574958 at CPT1A
0 − 560.399 0.292 0.064 2E-7 –
1 − 513.830 0.325 0.066 2E-8 0.085
2a − 511.765 0.319 0.066 4E-8 0.089
2b −509.989 0.311 0.066 1E-7 0.094
1–2 (Reduced) −511.893 0.316 0.062 1E-7 0.089 (age, age2, sex, age*sex age2*sex, current smoking)
3a − 510.396 0.251 (0.090) 0.082 (0.055) 1E-3 (4E-2) 0.091
3b − 508.105 0.359 (0.256) 0.074 (0.087) 1E-8 (3E-3) 0.089
cg17058475 at CPT1A
0 − 692.475 0.302 0.069 4E-7 –
1 − 668.034 0.365 0.071 4E-9 0.038
2a − 665.591 0.356 0.071 9E-9 0.042
2b − 662.173 0.351 0.071 1E-8 0.051
1–2 (Reduced) − 666.050 0.355 0.071 8E-9 0.043 (age, current smoking)
3a −665.471 0.298 (0.062) 0.092 (0.060) 8E-4 (1E-1) 0.044
3b NC
cg18181703 in SOCS3
0 − 555.561 0.486 0.063 8E-18 –
1 − 518.163 0.557 0.063 2E-21 0.055
2a − 517.421 0.551 0.064 4E-21 0.058
2b −514.324 0.559 0.063 1E-21 0.062
1–2 (Reduced) − 515.994 0.566 0.063 3E-22 0.057 (age, age2, center, current and former smoking)
3a −515.889 0.553 (0.020) 0.071 (0.045) 1E-11 (3E-1) 0.062
3b −515.663 0.585 (0.085) 0.068 (0.104) 2E-22 (2E-1) 0.060
cg06500161 in ABCG1
0 − 195.927 0.323 0.070 3E-8 –
1 −181.366 0.330 0.069 1E-8 0.028
2a −177.208 0.313 0.069 1E-7 0.039
2b −176.433 0.305 0.069 1E-7 0.041
1–2 (Reduced) − 184.146 0.306 0.069 1E-7 0.026 (sex, center)
3b NC
3c NC
Abbreviations: c2 Household variance component, h2 heritability variance component, NC nonconvergence of the household variance component model(s), Prop
Var Exp by Covar proportion of variance explained by covariates, SNP single nucleotide polymorphisms
aThe fixed covariates introduced in a stepwise fashion across Models 1 (age, age2, sex, age*sex, age2*sex), 2a (center), and 2b (current and former smoking,
indicator variables) were then screened at p < 0.1, to yield a reduced model. Then in Models 3a (‘early life’ shared environment, 647 siblings or half-siblings, within
15 years of each other in 255 households) and 3b (‘later life’ shared environment; 128 parents, or in the case of multiple pairings those with the youngest
offspring, in 64 households) variance components were separately introduced individually to this reduced model
Fernández-Rhodes et al. BMC Genetics 2018, 19(Suppl 1):69 Page 9 of 140
Familial correlations
The expected intra−/interclass correlation for each relative
pair is a function of the pairs’ expected relatedness and
the CpG site-specific heritability. We estimated weighted
correlations using the FCORR module of the S.A.G.E.
version 6.4 package (http://darwin.cwru.edu/sage/) within
various pair types, representing a quasi-independent sub-
set of the family pedigrees. We contrasted our correlations
before and after creating a residual of methylation to ac-
count for the fixed effects identified in multiple reduced
heritability models, and among a subset of unrelated indi-
vidual pairs.
Results
Heritability of MetS
The prevalence of MetS at the baseline examination of
GOLDN was 38.4% and its heritability was 0.47 (Stand-
ard Error, SE = 0.10; P value = 1E-5, n = 1103) in a model
where fixed effects (age, age2, and sex; P value < 0.1)
explained 13% of the variation in MetS. Separately,
we included variance components for early life shared en-
vironment (c2 = 0.21, SE = 0.09, P value = 7E-3), or later life
shared environment (c2 = 0.40, SE = 0.16, P value = 0.01).
Although the addition of these terms influenced the magni-
tude of the heritability estimates (h2 = 0.32, SE = 0.13 and
Fig. 1 Forest plot of MetS CpG methylation heritability estimates and 95% confidence intervals among converged models (in black) that were
unadjusted (Model 0) or adjusted for demographic and environmental factors (Models 1 and 2), or for shared early and late life environment
(Model 3a, 3b)
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h2 = 0.52, SE = 0.12, respectively), the resulting heritability
estimates did not differ significantly.
When we added fixed effects for the 4 MetS CpG sites
into the model without shared environment-related variance
components, two of the CpG sites (cg00574958 at CPT1A,
cg06500161 at ABCG1; P value <7E-5) were strongly
associated with MetS and another site (cg18181703 at
SOCS3; P value = 0.07) was suggestively associated with
MetS. Retaining these 3 sites in the polygenic model
decreased the heritability estimate slightly (h2 = 0.43,
SE = 0.12, P value = 2E-5) and increased the variance
explained (VE) by all the fixed covariates to 18%. The
addition of random effects of early life shared environ-
ment (c2 = 0.23, SE = 0.11, P value = 0.01) decreased the
heritability estimate (h2 = 0.24, SE = 0.15, P value = 0.05),
resulting in a nonsignificant MetS heritability estimate,
whereas accounting for shared late life environment
(c2 = 0.28, SE = 0.19, P value = 0.07) increased the herit-
ability only slightly (h2 = 0.46, SE = 0.12, P value = 1E-5).
Heritability of MetS methylation sites
The CpG site heritability estimates varied across models
(Table 1), although such differences were nonsignificant
(Fig. 1). The CpG site at SOCS3 was found to be highly
heritable with a value of 40% or higher in all models.
Notably, when convergence was achieved heritability
estimates at all CpG sites were robust to inclusion of
early life and late life shared familial environments, sug-
gesting a minimal inflation of CpG site heritability esti-
mates resulting from these shared environments. For
cg00574958 at CPT1A, shared early and later life vari-
ance components were both significant (Table 1).
For the two CPT1A CpG sites, which were correlated
at 0.74 in our data, 1 distant (±250–500 kb) variant,
Table 2 Variation in estimated intra- and interclass correlation coefficients across relative paired groups and subtypes (N > 50) at 3
MetS-related CpG methylation loci unadjusted and adjusted for fixed covariates in 993 participants from 188 families with
nonmissing covariates and methylation information at visit 2 in the GOLDN study
Pair Type Na Familial Correlations
Expectationb cg00574958 at CPT1A cg17058475 at CPT1A cg18181703 in SOCS3 cg06500161 in ABCG1
h2 = 0.316 h2 = 0.355 h2 = 0.566 h2 = 0.306
Unadj. Adj. Unadj. Adj. Unadj. Adj. Unadj. Adj.
Parent–offspring 541 h2/2 0.1721 0.1578 0.0986 0.0900 0.2964 0.2887 0.2267 0.2081
Mother–daughter 158 h2/2 0.2240 0.2565 0.2094 0.2572 0.2590 0.2591 0.1755 0.1537
Mother–son 146 h2/2 0.2302 0.1868 0.0750 0.0625 0.2207 0.2525 0.1775 0.1766
Father–daughter 129 h2/2 0.0422 0.0729 0.1766 0.1774 0.4510 0.4239 0.3417 0.3415
Father–son 108 h2/2 0.1967 0.2588 0.0480 0.0172 0.2813 0.2477 0.2071 0.1982
Siblings 588 h2/2 0.2224 0.1906 0.2071 0.2043 0.3295 0.3114 0.1185 0.1039
Brother–brother 145 h2/2 0.2396 0.2333 0.2328 0.2359 0.2668 0.2413 0.0647 0.0555
Sister–brother 276 h2/2 0.2075 0.1562 0.1496 0.1556 0.3252 0.2774 0.1187 0.0978
Sister–sister 167 h2/2 0.2245 0.3141 0.2680 0.2517 0.3769 0.3577 0.1490 0.1478
Grandparents–grandchildren 75 h2/4 0.0924 0.1020 0.0781 0.0807 0.3342 0.2892 0.0164 0.0064
Avuncular 553 h2/4 0.0685 0.0893 0.1323 0.1272 0.1440 0.1691 0.1632 0.1410
First cousins 247 h2/8 0.0227 0.0007 − 0.0393 − 0.0584 − 0.1394 − 0.1392 0.1411 0.1362
Great-avuncular 53 h2/8 0.0005 0.0266 0.1279 0.2092 − 0.0215 − 0.0453 0.5514 0.5249
First cousins once removed 71 h2/16 0.0486 0.1987 0.3085 0.2066 − 0.2466 − 0.2190 0.2418 0.1984
Parent–parent 65 0 0.1412 0.1221 − 0.0982 − 0.1432 0.0507 0.0164 0.0613 0.0505
Unrelatedc 91 0 − 0.0089 − 0.0236 0.0126 − 0.0231 − 0.0181 − 0.0235 − 0.0011 − 0.0002
MS Concordant 91 0 0.1420 0.1130 0.1602 0.1270 − 0.0399 − 0.0580 − 0.0051 − 0.0408
MS Discordant 76 0 − 0.1354 − 0.1284 − 0.1547 − 0.1515 − 0.1718 − 0.1566 0.0291 0.1017
Values in bold represent estimates that are nonzero with a P value < 0.05
Abbreviations: Adj. Calculated on residuals created after adjusting for fixed covariates age, age2, sex, center, and current smoking, MS National Cholesterol
Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Metabolic Syndrome status at visit 2, Unadj.
unadjusted for any covariates
aPairings may not be independent
bThe expected correlation under a genetic model with a heritability of h2
cOverall unrelated correlation assigned by subsetting to the 182 individuals from distinct families and randomly pairing them, whereas concordant and discordant
strata were calculated after randomly pairing within or across the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment
of High Blood Cholesterol in Adults criteria for MetS cases (N = 76) and controls (N = 106)
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rs17601808, was significantly associated with cg00574958
(P value = 0.01) and cg17058475 heritability estimates
(P value = 5E-3) after accounting for fixed effects from the
reduced model (see Table 1), resulting in significant but
attenuated heritability estimates (h2 = 0.24, P value = 5E-4,
VE = 11.8%; h2 = 0.31, P value = 2E-5, VE = 6.2%; respect-
ively). For the SOCS3 site, one local (±250 kb) genetic
variant, rs7220979, and two distant variants, rs9908993 and
rs17736494, were significantly associated with cg18181703
heritability after accounting for fixed effects (P values
≤0.05), resulting in similar heritability estimates (h2 = 0.58,
P value = 1E-14; VE = 7.7%) as in previous models. Includ-
ing these 3 SNPs resulted in nonsignificant estimates for
center and former smoking, and dropping these nonsig-
nificant fixed covariates also yielded similar heritability
estimates (h2 = 0.57, P value = 1E-14; VE = 7.4%). At the
ABCG1 site, 2 local (rs220245 and rs225434, P values = 0.03
and to 3E-4) and 1 distant genetic variant (rs8128650,
P value = 0.04) were associated with cg06500161 heritabil-
ity (h2 = 0.32, P value = 5E-5, VE = 6.8%) after accounting
for fixed effects.
Familial correlations
We then estimated familial coefficients across a number
of relationship pairings, before and after creating a re-
sidual adjusting for age, age2, sex, center, and current
smoking, which were retained in more than 1 reduced
heritability model (see Table 1). The use of residuals to
account for these fixed covariates generally decreased
the estimates slightly (Table 2). We also observed that
strata informed by more relative pairs (eg, parent–off-
spring, sibling and avuncular) exhibited correlations closer
to our expectation based on relatedness and the observed
heritability of the specific CpG site (see Fig. 2). For example,
for cg18181703 in SOCS3 the correlations estimated for
each of these relative pairs as well as grandparent–grand-
children were nominally significant (P value < 0.05), and
were 0.01 to 0.15 greater than our expected correlation.
Although not statistically significantly different from
other pairings (heterogeneity P value ≥0.3), the correlations
estimated for sister pairs were the largest across all sites
(see Table 2). We observed nonsignificant (P values ≥0.4)
positive correlations at 3 CpG sites among parent pairs (65
independent pairs), which were between 0.02 and 0.12
greater than expected. Among unrelated pairs, we observed
correlations that were closer to our expectation of no cor-
relation (eg, all within 0.02 of zero), which supports the up-
ward bias of shared household environments on familial
correlations. When we further paired this unrelated with
respect to MetS status, the correlation at the 2 CPT1A
CpG sites were biased upwards among concordant pairs,
and downwards from the null among discordant pairs.
Discussion
Although several animal models have established the trans-
generational epigenetic inheritance of metabolic diseases,
substantial hurdles remain to describing the inheritance of
DNA methylation in humans [4]. This is partly because of
the currently limited availability of large multigenerational
or family-based studies with CpG methylation data and
other relevant social and environmental factors. Previous
studies found that the methylome-wide heritability patterns
reflect negligible heritability at most CpG sites, and that
some CpG sites (14–80%) are regulated, in part, by local
genetic variation [7, 13, 14]. Only one previous study has
also tried to portion the variance caused by shared environ-
mental factors as a means of better understanding how
methylation may be inherited across generations, concluding
Fig. 2 Four CpG methylation sites for metabolic syndrome and their expected and observed correlations of relative pairs after accounting for age,
age2, sex, center, and current smoking showing clustering along the line of unity (in black)
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that shared environments, captured by nuclear family mem-
bership, contribute little to the observed methylome herit-
ability [13]. In contrast, our overall findings support roles for
both shared environment and genetic variation in explaining
the heritability at the 4 CpG sites in 3 methylation loci pre-
viously associated with MetS or several of its subcompo-
nents that we considered.
We observed an improvement of our MetS heritability
estimates after including CpG sites, which is consistent with
the transgenerational epigenetic inheritance as a contributor
to the missing heritability in complex traits like MetS.
We found that CpG site heritability estimates generally
increased as additional fixed effects for environmental
and genetic covariates were added to the variance com-
ponent model, but that the heritability estimates were
statistically indistinguishable. Although including ran-
dom effects of early or late life shared environments also
did not markedly change CpG heritability estimates, we
were able to identify a measurable, and at times significant
influence of shared environment on MetS and CpG site
heritability, which affirms the joint role of both shared
environmental and genetic influences on MetS and related
methylation. These observations collectively point to the
methodologic importance of including shared environ-
mental factors, especially in childhood or adolescence,
when modeling heritability estimates at later time points.
Additionally, we estimated familial correlations (with
and without adjustments for key covariates) across vari-
ous types of relative pairs. We observed that correlations
generally followed our expectation based on relatedness,
but in the case of sister and parent pairs we observed
nonsignificant trends toward greater correlation than ex-
pected. We posit that shared social and environmental
factors may make particular relative pairs appear more
similar than we would expect based on their relatedness
alone, which could lead to further inflation of heritability
and familial correlation estimates.
Conclusions
Previous research has not been able to address the ex-
tent of inflation of epigenetic inheritance estimates by
shared environmental effects, even though the sharing of
social or environmental exposures within households
may be a key driver of the observed similarity of methyla-
tion profiles within families [7, 13, 14]. Our results indi-
cate that MetS CpG site heritability is extremely robust,
even though both shared environmental and genetic influ-
ences play roles in the intergenerational patterning at
these sites. Although the current analysis brings us a step
closer to deciphering the complex action of transgenera-
tional epigenetic inheritance, shared environments, and
genetic variation in DNA methylation profiles in humans,
without much larger families including 3 or more genera-
tions or richer data on life course environmental risk
factors, we are unable to fully decompose the role of each
actor at the CpG sites for MetS considered here. Yet, this
study does outline an interesting and a flexible statistical
framework for testing such models in the context of hu-
man family studies. Future work should consider these,
and other methods, to replicate our heritability and famil-
ial correlation findings to further describe the mechanisms
of epigenetic inheritance in human populations.
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